• 1
    Elias Ja, Schreiber Ad, Gustilo K etal. Differential interleukin-1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol 1985;135: 31983204..
  • 2
    Szabo G, Miller-graziano Cl, Wu Jy et al. Differential tumor necrosis factor production by human monocyte subsets. J Leukoc Biol 1990;47: 206216.
  • 3
    Szabo G, Miller Cl, Kodys K. Antigen presentation by the CD4 positive monocyte subset. J Leukoc Biol 1990;47: 111120.
  • 4
    Akiyama Y, Stevenson Gw, Schlick E et al. Differential ability of human blood monocyte subsets to release various cytokines. J Leukoc Biol 1985;37: 519530.
  • 5
    Akiyama Y, Miller Pj, Thurman Gb et al. Characterization of a human blood monocyte subset with low peroxidase activity. J Clin Invest 1983;72: 10931105.
  • 6
    Yasaka T, Mantich Nm, Boxer La etal. Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol 1981;127: 15151518.
  • 7
    Figdor Cg, Bont Ws, Touw I et al. Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood 1982;60: 4653.
  • 8
    Connor Ri, Shen L, Fanger Mw. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level. J Immunol 1990;145: 14831489.
  • 9
    Szeberenyi Jb, Rothe G, Pallinger E et al. Multi-color analysis of monocyte and dendritic cell precursor heterogeneity in whole blood. Immunobiology 2000;202: 5158.
  • 10
    Grage-griebenow E, Flad Hd, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001;69: 1120.
  • 11
    Grage-griebenow E, Flad Hd, Ernst M et al. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 2000;202: 4250.
  • 12
    Hubl W, Ziegler-heitbrock Lh, Bayer Pm. A simple method for measurement of CD14weak CD16strong monocytes in peripheralblood. Immunobiology 2000;202: 210.
  • 13
    Grage-griebenow E, Zawatzky R, Kahlert H et al. Identification of a novel dendritic cell-like subset of CD64 (+) / CD16 (+) blood monocytes. Eur J Immunol 2001;31: 4856.
  • 14
    Fernandez Rc, Lee Sh, Fernandez La et al. Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J Interferon Res 1986;6: 573580.
  • 15
    Hanifin Jm, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol 1980;92: 4447.
  • 16
    Johansson Sgo, Hourihane Jo'b, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56: 813824.
  • 17
    Hanifin Jm, Thurston M, Omoto M et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001;10: 1118.
  • 18
    Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107: 535541.
  • 19
    Novak N, Bieber T, Katoh N. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001;167: 797804.
  • 20
    Thomas R, Lipsky Pe. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 1994;153: 40164028.
  • 21
    Zheng M, Mrowietz U. Phenotypic differences between human blood monocyte subpopulations in psoriasis and atopic dermatitis. J Dermatol 1997;24: 370378.
  • 22
    Chan Sc, Kim Jw, Henderson Wr Jr,Hanifin Jm. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993;151: 33453352.
  • 23
    Snijders A, Van Der Pouw Kraan Tc, Engel M et al. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin Exp Immunol 1998;111: 472476.
  • 24
    Weiner Lm, Li W, Holmes M et al. Phase I trial of recombinant macrophage colony- stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 1994;54: 40844090.
  • 25
    Schmid I, Baldwin Gc, Jacobs El etal. Alterations in phenotype and cell-surface antigen expression levels ofhumanmonocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry 1995;22: 103110.
  • 26
    Weiner Lm, Li W, Holmes M et al. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 1994;54: 40844090.
  • 27
    Wollenberg A, Wen S, Bieber T. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases. Lancet 1995;346: 16261627.
  • 28
    Panhans-groß A, Novak N, Kraft S, Bieber T. Human epidermalLangerhans' cells are targets for the immunsuppressive macrolide tacrolimus (FK 506). JAllergy Clinic Immunol 2001;107: 345352.
  • 29
    Wollenberg A, Sharma S, Von Bubnoff D, Geiger E, Haberstok J, Bieber T. Topical tacrolimus (FK 506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clinic Immunol 2001;107: 519525.